FDA and NIH, as part of an on-going interagency partnership, awarded 14 Tobacco Centers of Regulatory Science (TCORS) in order to generate critical research that informs the regulation of tobacco products. The research centers will receive more than $273 million in grants from 2013-2018. What scientists are learning about tobacco through the TCORS program is helping to inform and assess FDA's prior, ongoing, and potential regulatory activities. TCORS investigators also have the flexibility and capacity to respond to FDA's research needs as issues are raised in today's rapidly evolving tobacco marketplace.
Investing in Tobacco Regulatory Science
The TCORS program is designed to generate scientific evidence in seven key areas:
- Diversity of tobacco products
- Reducing addiction
- Reducing toxicity and carcinogenicity
- Adverse health consequences
- Marketing of tobacco products
- Economics and policies
The TCORS Scientists
TCORS proposals were selected for funding based on scientific and technical merit as determined by NIH scientific peer review, availability of funds, and relevance of the proposed projects to the TCORS program priorities.
The following organizations and investigators received grants:
Significant updates on the TCORS projects will be posted on this webpage, as well as on the NIH's Tobacco Regulatory Science Program (TRSP)'s TCORS webpage.